ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Yan Liu, Zhijian Guo, Jiayi Yang and Xuanwei Zhou
School of Agriculture and Biology, and Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, People’s Republic of China.
Article Number: 9797 | © The Author(s). 2025
J Pure Appl Microbiol. 2025;19(1):476-484. https://doi.org/10.22207/JPAM.19.1.38
Received: 16 July 2024 | Accepted: 12 December 2024 | Published online: 27 February 2025
Issue online: March 2025
Abstract

The Ganoderma lucidum immunomodulatory protein (FIP-glu) holds promise as a potential anti-tumor therapeutic agent. Enhancing the expression and stability of the engineered yeast strain is crucial for its industrial viability. This study focused on optimizing the fermentation parameters to produce an N-glycosylated protein, designated T36N, using the engineered Pichia pastoris GS115 strain with a mutant gene FIP-glu_T36N, a FIP-glu variant with an N-linked glycan modification. The response surface methodology (RSM) was employed to investigate the fermentation parameters that influence the yield of the N-glycosylated protein. Initially, the impact of fermentation duration on the optical density (OD600) and protein yield of P. pastoris GS115 were assessed, leading to the determination of a 96-hour fermentation period as optimal. Subsequently, the interplay among fermentation temperature, initial pH, and methanol concentration on protein yield was explored. The RSM analysis revealed the most favorable conditions for fermentation: a temperature of 26 °C, an initial pH of 6.5, and a methanol concentration of 1.00%. Verification tests confirmed that under these optimized conditions, the T36N yield peaked at 346.64 ± 3.47 mg.L-1, marking a 32.9% increase. The results underscored the capability of achieving high yields of T36N through the optimization of P. pastoris GS115 fermentation conditions. This research laid the groundwork for the industrial-scale production of N-glycosylated immunomodulatory proteins, offering a platform for the development of novel therapeutic agents.

Keywords

N-glycosylated, Fungal Immunomodulatory Protein, Fermentation Conditions, Optimization

Article Metrics

Article View: 270

Share This Article

© The Author(s) 2025. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.